Accumulation of aberrant DNA methylation during colorectal cancer development

Eiji Sakai1, Atsushi Nakajima1, Atsushi Kaneda1

  • 1Eiji Sakai, Atsushi Nakajima, Department of Gastroenterology, Yokohama City University School of Medicine, Yokohama 236-0027, Japan.

Insights

DNA methylation patterns classify colorectal cancer (CRC) subtypes and may predict cancer risk. This epigenetic mechanism is crucial for early detection and personalized treatment strategies for colorectal cancer.

Area of Science:

  • Epigenetics
  • Molecular Oncology
  • Cancer Genomics

Background:

  • Colorectal cancer (CRC) remains a leading cause of cancer mortality despite therapeutic advances.
  • CRC development involves accumulating genetic and epigenetic alterations, notably gene silencing via aberrant DNA methylation.
  • DNA methylation plays a critical role in the epigenetic landscape of colorectal cancer.

Purpose of the Study:

  • To review the role of DNA methylation in classifying colorectal cancer (CRC).
  • To explore the potential clinical utility of DNA methylation as biomarkers for CRC diagnosis, prognosis, and therapy response.
  • To discuss how DNA methylation patterns in normal colonic mucosa may predict individual CRC risk.

Main Methods:

  • Genome-wide methylation analyses to classify sporadic CRC into distinct epigenotypes.
  • Analysis of methylation patterns in precursor lesions (adenomas) and normal colonic mucosa.
  • Review of existing literature on DNA methylation and CRC.

Main Results:

  • Sporadic CRC can be categorized into distinct epigenotypes, each associated with specific genetic alterations, indicating different carcinogenic pathways.
  • Precursor lesions like conventional and serrated adenomas exhibit methylation accumulation similar to CRC, aligning with these epigenotypes.
  • Aberrant DNA methylation occurs early, even in normal colonic mucosa, suggesting its potential for predicting CRC risk.

Conclusions:

  • DNA methylation is a key epigenetic mechanism driving CRC development and classification.
  • Epigenotypes identified through methylation analysis offer insights into distinct molecular pathways of CRC.
  • DNA methylation holds significant promise as a biomarker for early diagnosis, prognosis prediction, and guiding therapy response in colorectal cancer.

Related Concept Videos

Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
28.5K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
29.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.3K